GnRH Therapy on Cognition in Down Syndrome
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Alzheimer Disease, Early Onset
- Cognitive Decline
- Down Syndrome
- Olfaction Disorders
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: A pilot study (n=12) will be conducted to verify the feasibility and the efficacy of the therapy on cognition and olfaction in this population. A randomized clinical trial will follow the pilot study if at least one among the cognitive or olfactory scores will significantly improve (>=10%).Masking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 40 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04390646
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Nelly Pitteloud, MD Endocrinology, Metabolism, Diabetology (CHUV)